Paper39167199
Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213.
Lin TC and 5 others. Childs Nerv Syst, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213. Papers, record 39167199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39167199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Moyamoya syndrome after proton beam therapy in a pediatric patient with a pineal germ cell tumor and a germline polymorphism in RNF213.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Moyamoya Disease | Major topic |
| Ubiquitin-Protein Ligases | Major topic |
| Proton Therapy | Major topic |
| Adenosine Triphosphatases | Major topic |
| Humans | |
| Male | |
| Child | |
| Neoplasms, Germ Cell and Embryonal | |
| Pinealoma | |
| Brain Neoplasms | |
| Germ-Line Mutation | |
| Polymorphism, Genetic | |
| Pineal Gland |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27038981 | Is Quasi-moyamoya Disease a Uniform Disease Entity? A Three-Dimensional Constructive Interference in Steady State Imaging Study. | J Stroke Cerebrovasc Dis | 2016 | https://conductscience.org/library/papers/27038981 | PubMed |
| 2 | 7839383 | Progressive cerebral occlusive disease after radiation therapy. | Stroke | 1995 | https://conductscience.org/library/papers/7839383 | PubMed |
| 3 | 23850618 | Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. | Biochem Biophys Res Commun | 2013 | https://conductscience.org/library/papers/23850618 | PubMed |
| 4 | 29730064 | Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors. | Int J Radiat Oncol Biol Phys | 2018 | https://conductscience.org/library/papers/29730064 | PubMed |
| 5 | 30157848 | Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line. | BMC Med Genomics | 2018 | https://conductscience.org/library/papers/30157848 | PubMed |
| 6 | 27193755 | Radiation-Induced Moyamoya Syndrome after Proton Beam Therapy in the Pediatric Patient: A Case Series. | Pediatr Neurosurg | 2016 | https://conductscience.org/library/papers/27193755 | PubMed |
| 7 | 26126547 | Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo. | J Am Heart Assoc | 2015 | https://conductscience.org/library/papers/26126547 | PubMed |
| 8 | 21048783 | A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. | J Hum Genet | 2011 | https://conductscience.org/library/papers/21048783 | PubMed |
| 9 | 21799892 | Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. | PLoS One | 2011 | https://conductscience.org/library/papers/21799892 | PubMed |
| 10 | 29657988 | Outcomes for pediatric patients with central nervous system germ cell tumors treated with proton therapy. | Clin Transl Radiat Oncol | 2016 | https://conductscience.org/library/papers/29657988 | PubMed |
| 11 | 36738468 | Neurosurgical management of proton beam therapy-induced moyamoya syndrome. | J Neurosurg Pediatr | 2023 | https://conductscience.org/library/papers/36738468 | PubMed |
| 12 | 27744643 | Proton therapy in paediatric oncology: an Irish perspective. | Ir J Med Sci | 2017 | https://conductscience.org/library/papers/27744643 | PubMed |
| 13 | 35197402 | 2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society. | Neurol Med Chir (Tokyo) | 2022 | https://conductscience.org/library/papers/35197402 | PubMed |
| 14 | 18940695 | Moyamoya disease: current concepts and future perspectives. | Lancet Neurol | 2008 | https://conductscience.org/library/papers/18940695 | PubMed |
| 15 | 22688070 | Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. | Neurol Med Chir (Tokyo) | 2012 | https://conductscience.org/library/papers/22688070 | PubMed |
| 16 | 33664967 | Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors. | Neurooncol Pract | 2021 | https://conductscience.org/library/papers/33664967 | PubMed |
| 17 | 35613882 | Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version. | Neurol Med Chir (Tokyo) | 2022 | https://conductscience.org/library/papers/35613882 | PubMed |
| 18 | 32387488 | Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation. | Radiother Oncol | 2020 | https://conductscience.org/library/papers/32387488 | PubMed |
| 19 | 8890997 | Occlusion of the anterior cerebral artery after Gamma Knife irradiation in a rat. | Acta Neurochir (Wien) | 1996 | https://conductscience.org/library/papers/8890997 | PubMed |
| 20 | 27662211 | Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells. | PLoS One | 2016 | https://conductscience.org/library/papers/27662211 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 40869185 | Multisystemic Impact of RNF213 Arg4810Lys: A Comprehensive Review of Moyamoya Disease and Associated Vasculopathies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869185 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RNF213 | 57674 | PubTator's text mining | https://conductscience.org/library/genes/57674 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39167199
GET https://conductscience.org/api/papers/v1/39167199/references?page=2